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1

Introduction

This is the evaluation framework for Cancer Australia’s National Lung Cancer Program (NLCP) as
proposed by the Centre for Health Service Development (CHSD), University of Wollongong.
The NLCP is a new program of Cancer Australia that has been funded for an initial four year
period from 2009 – 2013. The total budget allocation across this period is $6.83 million.
In designing the methodology for the program evaluation it is essential to be clear about the
purpose of the evaluation. For the NLCP, program evaluation has two key purposes to:
 Assess progress against the program objectives and;


Determine if the program is operating appropriately, effectively and efficiently.

1.1

Background

1.1.1

Summative and formative evaluation

In assessing progress against the NLCP objectives there are both summative and formative
evaluation tasks. Summative evaluation ascertains whether and to what extent the program was
implemented as intended and the desired/anticipated results achieved. This form of evaluation
usually occurs near the end-point of a program. The purpose is to ensure accountability and value
for money with the results of the evaluation informing any future planning decisions, policy and
resource allocation. This is evaluation for judgement (‘How did the NLCP do?’).
Formative evaluation more commonly occurs throughout the life of the program as it uses the
results of the evaluation to inform the ongoing development and improvement of the program. It
aims to improve the program throughout its implementation. This is evaluation for learning (‘How
can the NLCP learn and get better as it goes?).
Cancer Australia is committed to improving the delivery of their programs and ensuring that the
organisation as a whole monitors performance and delivers against the outcomes documented in
the Cancer Australia Strategic Plan 2011-2014 1.
1.1.2

Lapsing program evaluation

The NLCP has been funded by the Australian Government for a specified period. As this funding
period draws to a close an assessment can be made as to whether the program is meeting its
stated objectives. In order to secure further funding the NLCP will be subject to the Department of
Finance and Deregulation’s evaluation requirements for ongoing funding of a lapsing or
terminating program. This requires an assessment of the program’s appropriateness, efficiency
and effectiveness.
‘Program evaluation involves the systematic and objective assessment of government
programs or parts of programs, to assist the Government and other decision-makers to:

1

-

assess the continued relevance and priority of program objectives in the light of current
circumstances, including government policy changes (that is, appropriateness of the
program);

-

test whether the program outcomes achieve stated objectives (that is, its
effectiveness); and

Australian Government, Cancer Australia (August 2011). Cancer Australia: Strategic Plan 2011 – 2014.
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-

1.2

ascertain whether there are better ways of achieving these objectives (that is, its
efficiency)’. 2

Factors influencing the evaluation framework

The design of the NLCP evaluation framework must accommodate several factors. These include
the distinction between monitoring and evaluation; the foundation provided by the NLCP program
logic and the integration required with the broader performance evaluation processes within
Cancer Australia.
1.2.1

Monitoring and evaluation

The NLCP will need to monitor its performance through a small suite of Key Performance
Indicators (KPIs). For example, the projects that are funded must operate in accordance with an
agreed project management framework. Each project is monitored to ensure that milestones are
achieved and that the expected outputs are delivered. The program as a whole has a defined
budget allocation and officers of Cancer Australia monitor expenditure carefully throughout the
financial year to ensure that funds are used appropriately. Monitoring is something that occurs on
an ongoing basis and generates data that can be used to inform the evaluation when it occurs.
The evaluation framework aims to build upon these existing sources of information gathered
through routine monitoring and data collection. A range of additional data will need to be collected
as a ‘snapshot’ to answer the evaluation questions that form the core of the evaluation framework.
Suggested NLCP Key Performance Indicators for ‘monitoring’ purposes are included in Table 1
below.

Table 1

NLCP Key Performance Indicators

Program Objective

Key Performance Indicator

Increasing research to build the evidence around lung
cancer

1.

Number of NLCP publications that provide evidence to inform
priorities for cancer control

2.

Number of citations of NLCP funded scholarly publications

3.

Number of support and guidance projects completed on time
and within budget

4.

Number of web hits/downloads recorded for the new model of
care, and/or clinical guidelines

5.

Number of health professionals participating in spaced education
activities and/or using clinical guidelines.

Improving data and reporting for lung cancer.

6.

Number of downloads recorded for “Lung Cancer in Australia”
and “Report to the Nation on Lung Cancer”

Increasing engagement and effective partnerships for
the delivery of improved lung cancer care.

7.

Number of conjoint activities/partnerships with other cancer
organisations in which the NLCP has a leadership role

8.

Number of NLCP projects and engagement activities
demonstrating alignment with the CA National Framework for
Consumer Involvement in Cancer Control

9.

Number of NLCP projects that have evidence of formal
collaboration with organisations external to CA

Increasing support and guidance for health professionals
(through clinical guidelines and evidence based
information)

10. Departmental actual expenditure in a financial year comes within
10% of the original budget

2

Tune, D. (2010) Speaking Notes: Evaluation: Renewed Strategic Emphasis. Department of Finance and Deregulation.
Available at http://www.finance.gov.au/presentations/docs/speaking-notes-for-David-Tune-presentation-18-082010.pdf accessed 23 March 2011.
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1.2.2

Program logic and objectives

Developing the program logic is an important first step in an evaluation as it helps to make explicit
the program’s design and what the program is trying to achieve. The program logic for NLCP has
been documented separately and is included as Appendix 1 3. A summary diagram is provided in
Figure 1 below.
The program logic also drives the evaluation framework. This logic model establishes the links
between the Program’s inputs, activities, outputs, outcomes and impact. For example, one way of
thinking about ‘appropriateness’ is by asking the question: ‘Is the NLCP doing the right things?’ A
logic model can test the assumptions behind the activities in train and the causal link between the
strategies chosen and the desired outcomes.
The NLCP has three core objectives which guide the projects that are funded:
 Increase research to build the evidence around lung cancer


Increase support and guidance for health professionals



Improve data and reporting for lung cancer.

Figure 1

Cancer Australia National Lung Cancer Program Logic

National Lung Cancer Program Logic
Inputs-Activities
Outputs
Projects
These are listed in the
NLCP Work Plan and
include approximately 18
diverse projects linked
to each short term
objective.
Program Based
Include investments in
developing a robust
national program e.g.
development of the
National Lung Cancer
Advisory Group, and
efforts that contribute to
the organisational goals
of Cancer Australia e.g.
support for the PdCCRS

Short term
Objectives
2009-2013
Objective 1
Increase research to
build the evidence around
lung cancer
Objective 2
Increase support and
guidance for health
professionals
Objective 3
Improve data and
reporting for lung cancer
Objective 4
Increase engagement
and effective partnerships
for the delivery of improved
lung cancer care

Medium term
Required Changes
Health Promotion
Increase public awareness
and knowledge of lung
cancer symptoms and of
the utility of lung cancer
treatment
Prevention and Early
Detection
Increase early diagnosis
and referral of people
with lung cancer symptoms
Investigation and
Treatment
Increase knowledge of
lung cancer management
by health professionals.

Long term
Health Impact
Improved lung cancer
outcomes
Improved well-being of
people diagnosed with
lung cancer in Australia

Increase use of best
practice treatment and
supportive care.
Continuing Care
Improve access to
coordinated and
multidisciplinary care
for people with lung
cancer
System Improvement
Enhance the focus on
priority populations who
experience poorer health
outcomes
Improve leadership and
collaboration in the lung
cancer control community

3

Thompson C, Samsa P and Eagar K (2011) Evaluation Services for Cancer Australia’s National Lung Cancer Program:
Program Logic, Centre for Health Service Development, University of Wollongong.
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The NLCP as an initiative of Cancer Australia has a role in national leadership and coordination.
Consequently an additional opportunistic objective arises from the way the NLCP works with
organisations and jurisdictions which is to:
‘Increase engagement and effective partnerships for the delivery of improved lung cancer care’. 4
1.2.3

Cancer Australia Outcomes Hierarchy

Cancer Australia was established to benefit all Australians who are diagnosed with cancer, their
families and carers. Cancer Australia has four key outcomes which each program area
contributes to. These outcomes are to generate:
 Improvements in national coordination of cancer control and advice to Government


Improvements in cancer outcomes across the continuum of care



Improvements in the delivery of cancer care and the patient experience



Improvements in community knowledge that have the potential to impact on cancer outcomes. 5

Cancer Australia has identified how the organisation’s inputs and outputs as a whole can
progressively build to generate improved health outcomes for the Australian community, (refer to
Figure 2).
This hierarchy of outcomes shows that before higher order health outcomes can be achieved,
such as reduced mortality and the reform of systems and policy, there are preceding steps or
‘foundation’ activities that need to be completed. The work of the NLCP in its first phase of
operation has concentrated on these base building blocks or ‘foundation’ activities.

Figure 2

Interventions to Improve Cancer Outcomes 6

4

Cancer Australia Lung Cancer Program. Available at http://canceraustralia.gov.au/about-us/priorities-andprograms/lung-cancer-program accessed 29 July 2011.
5
Australian Government, Cancer Australia (August 2011). Cancer Australia: Strategic Plan 2011 – 2014, pp.19-20.
6
Ibid, p. 22.
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2

Evaluation strategy

The evaluation strategy has been designed to allow a judgment as to how successfully the NLCP
has been implemented, whether the desired results have been achieved and what lessons have
been learnt that will lay the ground-work for the future.
This program level evaluation does not seek to make judgements about the quality of outputs of
individual projects. The program-level evaluation will, in many respects, be a ‘roll-up’ of project
achievements, constraints and successes, driven from the perspective of the evaluation
framework. Given the diversity of projects there are no common outcomes that can be identified
across all projects, rather what is important is that projects align with the objectives of the NLCP
and are implemented as intended.

2.1

Elements of the evaluation

The cancer community is diverse and the NLCP aims to achieve improvements for consumers,
health providers and the broader health system, each of which needs to be considered in the
evaluation:
 Level 1: Impact on, and outcomes for, consumers (lung cancer patients, families, carers,
friends, communities)


Level 2: Impact on, and outcomes for, health providers (professionals, volunteers,
organisations)



Level 3: Impact on, and outcomes for, the system (structures and processes, networks,
relationships).

Figure 3

National Lung Cancer Program - Evaluation Elements

Evaluation
Hierarchy

What did you
do?

How did it go?

Can you keep it
going?

What has been
learnt?

Program/Project
Delivery

Program/Project
Impact

Program/Project
Sustainability

Program/Project
Capacity
Building

Are your
lessons useful
for someone
else?
Program/Project
Generalisability

Who did you
tell?

Dissemination

Level 1:
Consumers
(people with
lung cancer,
their carers,
family, friends,
communities)
Level 2:
Health
providers
(professionals,
volunteers,
organisations)

Level 3:
System for
managing lung
cancer control
(structure,
processes,
networks,
relationships)
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The evaluation framework is built around six program elements: program delivery, program impact,
sustainability, capacity building, generalisability and dissemination. Not all elements are relevant
to every project and objective of the NLCP. The shading in Figure 3 is to indicate that the main
focus of program delivery for the NLCP in this first funding phase, is in supporting health
providers/professionals (Level 2). This will in turn impact on people with lung cancer and the
system for lung cancer control.
The concepts of sustainability, capacity-building, generalisability and dissemination are mainly
issues for the delivery of the NLCP at Level 2. A brief explanation of these six areas is provided
below.
2.1.1

Program delivery

Program delivery (implementation) includes what was done and how it was done. Through
interviews with key stakeholders and review of project documentation it is possible to explore the
lessons learned about program implementation. The NLCP has funded a series of projects that
comprise the primary work or outputs of the program; a current project list is included as Appendix
2.
2.1.2

Program impact

The program as a whole is aiming to have an impact at three levels: the level of the consumer,
health service provider and broader health or cancer control system. Individual projects within the
program may be aiming to have an impact at one, two or all three of these levels. As the projects
are all quite different in nature it is logical to group the achievements in relation to each of the key
program objectives.
2.1.3

Sustainability

The various definitions of sustainability coalesce around two main ideas - sustainability of the
direct improvements made as part of a program, and the sustainability of the techniques and
approaches learnt as part of the program as well as any indirect benefits. Evaluation of
sustainability is closely aligned with the issue of capacity building (e.g. increased capability and
skills, increased resources) and any changes in structures and systems that ‘anchor’ or embed
changes and facilitate sustainability.
Several projects funded through the NLCP are not intended to be sustained. They have
contributed to short term outputs and may inform future initiatives but were not designed to be
ongoing. An example is the provision of travel grants for specialist lung care nurses to attend the
14th World Conference on Lung Cancer. This one-off activity aimed to build the capacity of these
nurses to contribute to the organisation of the next World Conference on Lung Cancer as it will be
held in Australia in 2013. Due to the short life of the NLCP and implementation stage of many
projects, sustainability is not a major focus of this evaluation.
2.1.4

Capacity building

Within the context of the NLCP, specifically the objectives of the program, capacity building has
two main components:
 Developing resources such as clinical guidelines, resources and other materials to support
evidence-based practice.


Other activities to improve the ongoing capacity of the NLCP e.g. development of a lung
cancer dataset and the Wiki platform.

Where possible data will be collected to demonstrate the extent to which the program has built
capacity in these areas.

Page 6
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2.1.5

Generalisability

As one program within Cancer Australia, the NLCP aims to transform data and information into
knowledge that can be applied in different contexts. This issue can be examined by looking at
how the NLCP might leverage off the broader organisation of Cancer Australia and conversely
how the NLCP contributes to the achievements of Cancer Australia. By reviewing the outputs of
the NLCP and seeking the opinion of those involved in the program it will also be possible to
investigate the extent to which the lessons learnt may be applied elsewhere.
2.1.6

Dissemination – sharing of knowledge

The issue of dissemination (who else learnt about the projects?) is closely linked to the issue of
generalisability (are the lessons useful for someone else?). The capacity of the NLCP to
communicate about successful projects, throughout the wider cancer control sector, is important.
This includes examination of the formal and informal mechanisms and processes for disseminating
improvements.

2.2

Appropriateness, Efficiency and Effectiveness

In addition to the six program elements described in Section 2.1, the evaluation framework also
needs to capture data that will explain how the NLCP has addressed the Australian Government’s
requirements for appropriateness, efficiency and effectiveness.
One way of thinking about ‘appropriateness’ is by asking the question: ‘Is the NLCP doing the right
things?’ Appropriateness can be explored through the following questions:
 Is the program consistent with Government priorities?


Is there still a need for this program; are there any alternative strategies to address the need?



What are the consequences of not continuing this program?

Efficiency is defined as the extent to which the use of inputs is minimised for a given level of
outputs, or outputs are maximised for the given level of inputs. Efficiency is concerned with:


inputs – the resources used



the processes by which the program is delivered



outputs – the deliverables or products delivered by the program (for example, number of
resources delivered, scholarships or grants awarded, health providers who accessed training
etc.)

Effectiveness describes the extent to which the program’s outputs have made a positive
contribution to the specified outcome. Effectiveness indicators are used to assess the degree of
success in achieving outcomes. Evaluating effectiveness involves asking the questions:


Which factors affect achievement of outcomes?



Are there any cause-effect interpretations as to whether the outcomes were caused by the
program, or caused by external factors?



Were there any unanticipated outcomes which are contributing to the achievement of
objectives or impacting negatively on consumers or health providers?

Evaluation questions that will address appropriateness, efficiency and effectiveness are integrated
throughout the evaluation framework. An example of how these issues are addressed is provided
in Table 2

Cancer Australia National Lung Cancer Program: Evaluation Framework
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Table 2

Addressing Appropriateness, Efficiency and Effectiveness

FOCUS

EVALUATION QUESTIONS

APPROPRIATENESS
Current government priorities

Is the program consistent with Government priorities?

Key program initiatives

Is there an optimal mix of individual initiatives that could meet
overall Program objectives?

Key program initiatives

Are the individual initiatives themselves appropriate?

Continuing need

Is there still a need for this program? Has the burden of disease
generated by lung cancer diminished?

Key program initiatives

Are there any clear gaps in the Program that might need to be
filled by additional projects?

Australian government funding

Is the Program likely to continue in the absence of government
funding? What are the consequences of not continuing this
program?

Possible improvements

What are some possible improvements that might be
considered to increase Program appropriateness and/or
sustainability?

EFFICIENCY
Duplication

Is there any duplication in Program initiatives that might be
reduced to improve efficiency?

Administration

Could the inputs, processes, outputs and administration of the
Program and its projects be improved?

Possible improvements

What are some possible improvements that might be
considered to increase Program efficiency?

EFFECTIVENESS
Program objectives

To what extent has the Program and individual funded projects,
been successful in achieving agreed objectives?

Outcomes

What are the key outputs and short term outcomes achieved as
a result of funding the Program?

Contribution to organisational goals

Has the NLCP added value to the work of CA in its plan to roll
out tumour-based programs? What are the lessons learnt for
CA in expanding its work?

Possible improvements

What are some possible improvements that might be
considered to improve Program effectiveness?

Page 8
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3

Evaluation framework

The evaluation framework has been designed to focus on the building blocks of the NLCP which
will be contributing to the next project phase. These activities provide the foundation necessary to
establish and maintain the program e.g. the development of the National Lung Cancer Advisory
Group.
Most of the projects funded in this first phase of the NLCP will only be in the initial stages of
implementation at the time of the evaluation, therefore evidence from this phase of the program
will mainly be output related. The program logic has been developed to ensure that program
outputs, where appropriate, can be built upon and contribute to medium and longer term
improvements in health outcomes.

3.1

Target groups

The key target groups being addressed by the Program are consumers, health providers and
partner organisations with which the NLCP aims to collaborate. Not every project addresses all
target groups.
The consumers include:
 People with lung cancer, their carers and families


The general community.

The providers include:


Primary care providers (including GPs, Practice Nurses, allied health professionals, Aboriginal
Health workers etc.)



Specialist lung service providers (including respiratory physicians, oncologists, surgeons, lung
nurses etc.).

The partner organisations include:


Organisations with a focus on cancer consumers



Organisations with a focus on health service providers working in the lung cancer or related
fields.

The NLCP also has responsibility for ensuring that it extends its reach to disadvantaged
communities including those living in rural and remote Australia, people of Aboriginal and Torres
Strait Islander backgrounds, people of Culturally and Linguistically Diverse backgrounds and those
of low socio-economic status.

3.2

Evaluation questions

A range of evaluation questions are provided in

Table 3 that cover the evaluation elements described in Section 2.1. These questions are linked
to the Program objectives and short term outcomes specified in the program logic. They aim to
address the outputs and outcomes of the NLCP for consumers, service providers and the broader
health system. Each evaluation question is also coded against the three lapsing program criteria:
“A” for appropriateness, “EI” for efficiency and “E” for effectiveness.
Cancer Australia National Lung Cancer Program: Evaluation Framework
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Table 3

Evaluation Framework to Address NLCP Objectives

OBJECTIVES
Level 1:

EVALUATION QUESTIONS

DATA SOURCES

Processes, impacts and outcomes for consumers (cancer sufferers, families, carers, friends, communities)

Increasing research
to build the evidence
around lung cancer

Increasing
engagement and
effective partnerships
for the delivery of
improved lung cancer
care.

A

DELIVERY
Were appropriate consumer
projects selected to be
funded?

Percentage of funded consumer
related projects that align with
NLCAG priorities

Documentary review of
NLCAG minutes and
consumer project
plans/progress reports
Stakeholder interview: CA
CEO, Chair & NLCAG
members, Program staff

EI

DELIVERY
Were the consumer projects
completed as intended?

EI

E



Translation of lung
cancer DVD



Review of lung cancer
patient information



Promotion of key
messages to the
community on symptoms
and early detection of
lung cancer

Were consumers involved in
the NLCP?

IMPACT
Were lung cancer DVDs for
consumers produced in
community languages?

Page 10

MEASURES

Percentage of consumer
projects that were completed on
time and on budget

Project records, (milestones,
deliverables)

Level of compliance/alignment
of projects with the principles of
the National Framework for
Consumer Involvement in
Cancer Control

Consumer involvement audit
tool

Number of lung cancer related
DVDs produced in each of
twelve community languages

Project records

Budget reports

Stakeholder interviews:
consumer representative(s)
NLCAG; CA personnel;
other nominated groups.

E

Did health professionals have
improved access to evidence
based consumer resources?

Number of downloads from
Australian Lung Foundation
web-site

Website analysis

E

What efforts where made to
incorporate the requirements
of ATSI and CALD consumers
in the Stigma and Nihilism and
Model of Care projects of the
NLCP?

Evidence of effort to address
the requirements of ATSI and
CALD consumers in relevant
projects of the NLCP

Audit tool for use prior to
contract finalisation

Cancer Australia National Lung Cancer Program: Evaluation Framework
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OBJECTIVES

EVALUATION QUESTIONS
E

DISSEMINATION
Were there any dissemination
activities?

Level 2:

MEASURES
Numbers of workshops,
presentations, publications

DATA SOURCES
Dissemination Log

Processes, impacts and outcomes for providers (professionals, volunteers, organisations)

Increasing research
to build the evidence
around lung cancer

A

DELIVERY
Were the appropriate research
projects selected to be
funded?

Level of alignment with
documented NLCAG research
priorities

Documentary review of
NLCAG minutes and
research project
plans/progress reports
Stakeholder interview: CA
CEO, Chair & NLCAG
members, Program staff

EI

DELIVERY
Were the research projects
completed as intended?

E



Research and report on
the effects of stigma and
nihilistic views on lung
cancer outcomes



Model of Care for the
management of lung
cancer



PdCCRS – Lung cancer
research priorities
(Project 1: Alternative
lengthening of telemeres
in lung cancer)



PdCCRS – Lung cancer
research priorities
(Project 2: Identifying
therapeutic targets by
profiling DNA repairing
lung cancer)



PdCCRS - Lung cancer
research priorities
(Additional projects in
alignment with agreed
lung cancer research
priorities 2011-2013)



Lung cancer risk factor
research



Investigating the
symptoms in lung cancer

IMPACT
What impact did the PdCCRS
research reports generate?

E

E

Percentage of research projects
completed on time and on
budget

Project records/progress
reports, (milestones,
deliverables)

Level of compliance with agreed
project milestones

Budget reports

Number of items submitted for
publication

Project records

Number of items placed on the
Cancer Australia web-site

What impact did the
systematic review on the
effects of stigma and nihilistic
views on lung cancer
outcomes have within the
Australian cancer control
sector?

Systematic review published in
a peer reviewed journal

Did all research projects
contribute to building the
evidence around lung cancer?

Number of research projects
that have prepared and/or
submitted a publication

Number of citations post
publication

Cancer Australia National Lung Cancer Program: Evaluation Framework

Web analysis
Project records

Citation report (note,
citations may not appear for
some time after publication)
Project records
Review with CA staff
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OBJECTIVES

EVALUATION QUESTIONS
E

DISSEMINATION
Were the research outputs
disseminated?

MEASURES
Number of conference
presentations/workshops by
NLCP staff, and by Projects
related personnel

DATA SOURCES
Dissemination Log

Number of publications
published, or planned for
publication
Increasing support
and guidance for
health professionals
(through clinical
guidelines and
evidence based
information)

A

DELIVERY
Were appropriate support and
guidance projects selected to
be funded?

Level of alignment with
documented NLCAG priorities

Stakeholder interview: CA
CEO, Chair & NLCAG
members, Program staff
EI

DELIVERY
Were the support and
guidance projects delivered as
intended?

E



The development and
validation of clinical
indicators for optimal lung
cancer care



Updating the 2004
Clinical Practice
Guidelines for the
prevention, diagnosis and
management of lung
cancer



Travel grants for IASLC
14th World Conference
on Lung Cancer in
Amsterdam



Translating Research into
Practice (TRIP) clinical
fellowship for lung cancer



Lung Cancer Spaced
Education program for
GPs



Development of a Lung
Cancer Risk factor
assessment tool for
General Practitioners

IMPACT
What impact did the support
and guidance projects have?

Percentage of support and
guidance projects completed on
time and on budget

E

Was the Lung Cancer Spaced
Education program for GPs
used?

Project records/progress
reports, (milestones,
deliverables)
Budget reports

Evidence of improved
information, guidelines and
support for GPs in lung cancer
management
Contribution of the NLCP to
increased confidence,
knowledge and capacity of
health professionals to manage
lung cancer within the primary
care setting
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Documentary review of
NLCAG minutes and
relevant project
plans/progress reports

Numbers of GPs completing
education program actvities

Project report records
relating to providers using
new models of care,
guidelines and consumer
resources
Web downloads of
resources
Stakeholder interviews:
health provider
organisations
Project documentation and
records
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OBJECTIVES

EVALUATION QUESTIONS
E

CAPACITY BUILDING
Did the Travel Grants project
improve the capacity of the
service system?

E

DISSEMINATION
Did the Translating Research
into Practice (TRIP) clinical
fellowship for lung cancer
disseminate knowledge to the
service sector?

Improving data and
reporting for lung
cancer.

A

DELIVERY
Were appropriate data and
information projects selected
to be funded?

MEASURES

DATA SOURCES

Number of lung cancer nurses
participating in travel grants
projects

Stakeholder interview: ALF,
NLCP staff, NLCAG
members

Number of lung cancer nurses
with a travel grant who are
contributing to the 15th World
Conference on Lung Cancer in
Australia

Survey - lung cancer nurse
network

Number of knowledge
dissemination activities

CA staff, NLCP staff,
NLCAG members, TRIP
fellows
Dissemination Log

Level of alignment with
documented NLCAG priorities

Documentary review of
NLCAG minutes and
relevant project
plans/progress reports
Stakeholder interview: CA
CEO, Chair & NLCAG
members, Program staff

EI

DELIVERY
Were the data projects
delivered as intended?

E



Development and pilot
testing of Lung Cancer
Data Set Specification



Capturing information on
clinical stage, metastases
at diagnosis and cancer
recurrence employing IT
solutions

IMPACT
What were the major lessons
learned through the
development and
implementation of the data
and reporting projects?

E

SUSTAINABILITY
How will the data and
reporting improvements be
sustained?

Percentage of support and
guidance projects completed on
time and on budget

Project records/progress
reports, (milestones,
deliverables)
Budget reports

Document unintended
consequences for Cancer
Australia

Stakeholder discussion, CA
staff, NLCP staff, NLCAG,
Project staff

Document major lessons
learned and program gaps

Dissemination log

Level of partnerships instituted
to support adoption of data and
reporting initiatives

Documentary review of
NLCAG minutes and
relevant project
plans/progress reports

Final version of dataset
endorsed by the National Data
Standards Group

Stakeholder interview: CA
CEO, Chair & NLCAG
members, Program staff
Dissemination log

E

CAPACITY BUILDING
Was there improved access to
data relating to lung cancer?

Increasing
engagement and
effective partnerships
for the delivery of
improved lung cancer
care.

EI

DELIVERY
How frequently has the
NLCAG met and what is the
level of participation?

Number of downloads from
AIHW web-site of lung cancer
report

Web analysis

Number of meetings of the
NLCAG and pattern of
attendance of members

Documentary review of
NLCAG minutes/papers

Cancer Australia National Lung Cancer Program: Evaluation Framework
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OBJECTIVES

EVALUATION QUESTIONS
E/A

IMPACT
What contribution has the
NLCAG made to the work of
the NLCP?

What is the contribution of
expert clinicians and service
providers to the NLCP?

MEASURES
Evidence of engagement with
NLCAG members
Evidence of consistency of
program initiatives with
Australian Government priorities

Participation of experts/service
providers in project working
groups

DATA SOURCES
Stakeholder interview, CA
staff, NLCP staff, NLCAG,
Projects staff
Documentary sources:
Portfolio Budget Statements

Meeting attendance audit
tool

Attendance of members of the
NLCAG at advisory group
meetings

What other partnerships has
the NLCP developed through
the work of the Program?

Level 3:

Stakeholder interview, CA
staff, NLCP staff, NLCAG,
Projects staff
Partnership survey

Processes, impacts and outcomes for the system (structures, processes, networks, relationships)

Increasing research
to build the evidence
around lung cancer
Increasing support
and guidance for
health professionals
(through clinical
guidelines and
evidence based
information)

EI

Increasing
engagement and
effective partnerships
for the delivery of
improved lung cancer
care.

DELIVERY
Were the data and reporting
projects delivered as
intended?

E

Improving data and
reporting for lung
cancer.
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Evidence of increased
networking and collaboration
within the lung cancer control
community



AIHW Report: Lung
Cancer in Australia



Report to the Nation on
Lung Cancer in Australia

IMPACT
Was there increased
knowledge of the extent and
effect of lung cancer amongst
the Australian public and
policy makers?

A

DELIVERY
Was the balance of effort
appropriate in the allocation of
funds between the key
program objectives?

Percentage of data and
reporting projects completed on
time and on budget

Project records, (milestones,
deliverables)

Number of downloads of reports
“Lung Cancer in Australia” and
“Report to the Nation on Lung
Cancer in Australia”

Website analysis

Budget reports

Publication satisfaction
survey
Media monitoring

Percentage of Program
expenditure per core objective

Document analysis of
project expenditure
Stakeholder interview: NLCP
staff, NLCAG members
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OBJECTIVES

EVALUATION QUESTIONS
EI

DELIVERY
Did the NLCP engage and
partner with relevant
organisations?

MEASURES

DATA SOURCES

Participation in relevant
meetings, with

Documentary records e.g.
minutes of meetings

Professional Associations

Stakeholder interviews



RACGP



Medical Oncology Group
of Australia

Key partner organisations,
survey (relationship tool)



Clinical Oncological
Society of Australia

Other Professional Networks


ALF (specialist lung
nurses)



Cancer Council Australia



Universities/Research
centres

Government:
Did the NLCP engage with
other jurisdictions through the
Model of Care project and
dissemination of the
Multidisciplinary Team
Directory?

A

IMPACT
Is there still a need for this
program?

A

IMPACT
Is the NLCP likely to continue
in the absence of government
funding?

E

IMPACT
Did the NLCP increase
networking and collaboration
within the lung cancer control
community?

A/E

SUSTAINABILITY
What are some possible
improvements that might
increase Program
sustainability and
effectiveness?



DOHA



State Jurisdictions

Evidence of burden of disease
generated by lung cancer in the
Australian community

Documentary sources
including NLCP publications
developed through AIHW

Perceptions of the
consequences of not continuing
this Program amongst key
stakeholders

Stakeholder interview: CA
CEO and Chair, NLCP staff,
members of the NLCAG

Perceptions of networking and
collaboration within the lung
cancer control community
amongst the NLCP and key
stakeholders

Stakeholder interview: CA
CEO and Chair, NLCP staff,
members of the NLCAG

Perceptions of areas of focus
for the future from key
stakeholders

Stakeholder interview: CA
CEO and Chair, NLCP staff,
members of the NLCAG

Surveys -Use of relationship
tool with key partners

Surveys -Use of relationship
tool with key partners

Surveys -Use of relationship
tool with key partners

EI

Is there any duplication in
Program initiatives that might
be reduced to improve
efficiency?

Evidence of project duplication
within CA

Stakeholder interview: CA
CEO and Chair, NLCP staff,

E

DISSEMINATION

Description of foundation
activities contributing to the
knowledge hub within CA

Stakeholder interview: CA
CEO and Chair, NLCP staff,
members of the NLCAG

Has the groundwork been
developed for further
dissemination of work that is
completed?

Cancer Australia National Lung Cancer Program: Evaluation Framework
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4

Methodological issues and data sources

Clear, well-articulated questions form the basis of designing the evaluation, however not all
questions to be answered by the evaluation can be made explicit at the beginning of the
evaluation. Some questions will emerge over the course of the evaluation as data is collected and
analysed. Some questions may need to be modified as the evaluation progresses, usually due to
the lack of appropriate means to collect the required data.
One issue in understanding the impact of the NLCP relates to the level of evidence. This can
either be at the level of ‘beyond reasonable doubt’ typically used in scientific research, or at the
level of ‘on the balance of probabilities’ typically used by policy makers and decision makers. The
aim is to frame the interpretation of the data, both quantitative and qualitative, according to the
latter.

4.1

Sources of data

The primary data sources listed in the evaluation framework include documentary sources,
stakeholder interviews, audit tools, surveys, dissemination logs, media monitoring and web
analysis. Each is described in turn below.
4.1.1

Documentary sources

A range of documents will be analysed during the evaluation to provide evidence of
appropriateness, efficiency and effectiveness. These include internal documentation relating to
the policies and operation of CA and the NLCP as well as external Government policies,
documents and legislation relevant to the area of cancer control.
A key documentary source includes the project plans, progress and budget reports. These reports
will be examined to see whether project milestones were met and projects were completed on
budget. The review of these reports may be supported by the development of a project checklist
and/or reporting template.
Minutes of meetings arranged and attended by NLCP staff with other lung cancer control agencies
will be reviewed to understand the nature of NLCP engagement with these agencies. The records
of meetings of the NLCAG are another valuable resource that captures the work and decisions of
this group.
4.1.2

Stakeholder interviews

Interviews are a rich source of qualitative data and allow more complex issues to be investigated
and understood. Therefore interviews with a range of key stakeholders will be an important data
collection tool. The selection of interviewees will be based on the need to:
 inform the program-level evaluation


guide and check the validity of findings from data analysis



check the quality of the data collected by other means



inform the dimensions of sustainability and dissemination



understand the process of program development and establishment.

Potential interviewees will be invited to consent and provided with a Participant Information Sheet
that will detail the purpose of the interview, and how the information gathered in the interview will
be used and stored.
Interviews that are likely to be short will be conducted by phone and recorded by the taking of
notes. In some cases an email response will be appropriate and will serve as the data collection
Page 16
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method. Longer interviews may need to be recorded digitally. The interviewer will make notes as
soon as possible after each interview to record their own observations and key points. Some time
later the interviewer will listen to the recording and extract the salient points and quotations from
the interviews. Recordings will be retained to allow for further analysis at a later data if there is a
need to do so.
In some cases it may be more efficient to use on-line survey tools when similar questions are to be
asked of a larger group of stakeholders.
The National Lung Cancer Advisory Group

The National Lung Cancer Advisory Group guides the NLCP and consists of a range of clinicians,
bureaucrats and consumers. The opinions of Group members will be sought on the range of
activities of the Program and how these activities align with priorities set by NLCAG. Their
opinions may be sought by individual interview, group discussion, or via an on-line survey.
Staff of Cancer Australia external to the NLCP

Several staff of CA have ongoing contact with the work of the Program. Their views will be sought
on how the project management of the NLCP may be improved, the effectiveness of the funded
projects and how the work of the NLCP aligns with the work of Cancer Australia, for example in
relation to the PdCCRS and mechanisms for consumer engagement. This information may be
sought by interview or an on-line survey.
NLCP staff

The staff with day to day responsibility for the operations of the NLCP are an important resource.
Their views will be sought on the effectiveness of the projects, and how improvements can be
made, for example to consumer involvement. Because of the depth of their knowledge, this will be
best done by interview.
Cancer Australia CEO and Chair

These individuals are well positioned to comment on the strategic impact of the NLCP and how the
NLCP currently contributes, and how in the future its work is planned to contribute, to the work of
Cancer Australia. Their input on these issues and how the NLCP aligns with Australian
Government policies and priorities will be sought by interview.
Cancer Australia’s National Consumer Advisory Group

The National Consumer Advisory Group provides formal advice to Cancer Australia on matters of
concern to consumers. Group members may have contributed at different times to the work of the
NLCP. If appropriate they will be asked to provide feedback on the appropriateness of the work of
the NLCP for consumers, and how it has impacted on consumers. This input will be sought by an
on-line survey.
Project staff

The vast majority of NLCP projects have been contracted out to a diverse group of researchers,
consultants and health service providers. It may be appropriate to gain the input of a sample of
these project contributors in relation to how the projects could have been implemented more
effectively and efficiently. This will be done via an on-line survey.
Key partner organisations

A number of organisations will be identified as key partner organisations by the NLCP and Cancer
Australia, for example, the NLCP works closely with the Australian Lung Foundation and the
Cancer Council of Australia. These organisations will be interviewed as to whether the NLCP has
increased networking and collaboration within the lung cancer control community.
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4.1.3

Surveys

Online surveys will be used to determine the effectiveness of NLCP activities in certain areas.
These will be developed using the Survey Monkey application as it is web based and can
efficiently collate quantitative survey results.
 A relationship tool may be used with other lung cancer control agencies to identify any
perceived changes in their relationship with the NLCP, and networking and collaboration
between agencies in this sector


A range of service providers could be surveyed to explore their use of resources provided by
the NLCP. These service providers may include:


Professional associations such as the Royal Australian College of General Practitioners,
Clinical Oncological Society of Australia etc.



Special interest service providers such as the Australian Lung Foundation



Non-government organisations such as Cancer Council Australia



Australian Government and State Government jurisdictions (in relation to specific and
relevant projects)
Another option may be to identify users of the NLCP web-site and ask them to participate in a
survey to evaluate web based information resources relating to lung cancer.
4.1.4

Audit tools

The analysis of documentary and web sources can be streamlined through the use of an
appropriate audit tool. In some cases standardised and validated tools may be available; in other
instances it may be useful to produce customised audit tools. These tools will be used to structure
the assessment of Program performance in several areas. For example the level of consumer
involvement in projects and/or efforts to incorporate the requirements of disadvantaged groups
could be measured through the use of consumer involvement audit tools.
4.1.5

Dissemination logs

It may be useful to track dissemination activities of projects as they proceed over the ensuing
months. A dissemination log could be created to assist NLCP staff to keep records of a range of
project related dissemination activities e.g. conference presentations; resource distribution, etc.
4.1.6

Media monitoring and web analysis

Usage of the NLCP web-site could be analysed to determine downloads of resources provided on
the web-site. This could be restricted to key publications such as the proposed Australian Institute
of Health and Welfare (AIHW) report “Lung Cancer in Australia”. AIHW provides a satisfaction or
‘publication effectiveness’ survey for documents downloaded from their web-site. This could also
be linked to the CA web-site and will provide feedback on users’ satisfaction. Google Scholar can
be used to track citations of any scholarly publications that arise out of NLCP projects. There
should also be an expectation that any publications will be jointly produced with CA.
Media monitoring may be used to identify mentions of the work of the NLCP that are broadcast in
the mainstream media in order to determine the reach of NLCP messages to the general public.
CA may already have a media monitoring service engaged.

4.2

Next steps

The next step in this process is refinement of the evaluation questions and key performance
indicators in collaboration with staff or the NLCP. It will then be possible to develop the tools to
support data collection for the evaluation.
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Appendix 2

National Lung Cancer Program Project List

Project Number

Project Title

1

Research and report on the effects of stigma and nihilistic views on lung cancer outcomes

2a

PdCCRS – Lung cancer research priorities (Project 1: Alternative lengthening of telemeres in lung
cancer)

2b

PdCCRS – Lung cancer research priorities (Project 2: Identifying therapeutic targets by profiling
DNA repairing lung cancer)

2c

PdCCRS - Lung cancer research priorities (Additional projects in alignment with agreed lung
cancer research priorities 2011-2013)

3

Lung cancer risk factor research

4

Model of Care for the management of lung cancer

5

Updating the 2004 Clinical Practice Guidelines for the prevention, diagnosis and management of
lung cancer

6

Investigating the symptoms in lung cancer

7

Translation of lung cancer DVD

8

Review of lung cancer patient information

9

Travel grants for IASLC 14th World Conference on Lung Cancer in Amsterdam

10

Translating Research into Practice (TRIP) clinical fellowship for lung cancer

11

Development and pilot testing of Lung Cancer Data Set Specification

12

AIHW Report: Lung Cancer in Australia

13

Capturing information on clinical stage, metastases at diagnosis and cancer recurrence employing
IT solutions

14

Report to the Nation on Lung Cancer in Australia – This will be a report derived from the AIHW
report that will provide easily accessible information about advances in cancer control for the
general public including the media

15

The development and validation of clinical indicators for optimal lung cancer care – This will be a
suite of clinical indicators for best practice in lung cancer that will be validated in the clinical
setting.

16

Promotion of key messages to the community on symptoms and early detection of lung cancer This will be printed and on-line information resources for people affected by lung cancer to support
the early detection and identification of lung cancer symptoms.

17

Development of a Lung Cancer Risk factor assessment tool for General Practitioners - this will
include undertaking a feasibility of developing a risk factor assessment tool for GPs and if feasible
development of the tool.

18

Lung Cancer Spaced Education program for GPs - This will include spaced education activities
that will be linked to Cancer Australia resources developed under the GP guide project
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